HC Wainwright Cuts Arcturus Therapeutics (NASDAQ:ARCT) Price Target to $60.00
Arcturus Therapeutics (NASDAQ:ARCT – Free Report) had its price target cut by HC Wainwright from $63.00 to $60.00 in a research report sent to investors on Friday,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. Several other brokerages have also commented on ARCT. BTIG Research initiated coverage on Arcturus Therapeutics in […]
Arcturus Therapeutics (NASDAQ:ARCT – Free Report) had its price target cut by HC Wainwright from $63.00 to $60.00 in a research report sent to investors on Friday,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. Several other brokerages have also commented on ARCT. BTIG Research initiated coverage on Arcturus Therapeutics in […]
